Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.38 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25847342 | 0.89 | HPGDS (0.44) | CYP1A2NCF1ADORA2ALMNAPDE10A | |
| SCHEMBL10671008 | 0.89 | PDE10A (0.47) | CYP1A2NCF1ADORA2ALMNAPDE10A | |
| SCHEMBL17532866 | 0.89 | LMNA (0.46) | CYP1A2LMNAHPGDSKDM4EMAPT | |
| SCHEMBL17932795 | 0.88 | MEN1 (0.46) | CYP1A2LMNAHPGDSGP6ALDH1A1 | |
| SCHEMBL16189098 | 0.88 | MEN1 (0.46) | CYP1A2LMNAHPGDSGP6ALDH1A1 | |
| SCHEMBL29118670 | 0.86 | RAB9A (0.43) | CYP1A2LMNAADORA1KDM4EALDH1A1 | |
| SCHEMBL8470699 | 0.83 | ABCG2 (0.37) | CYP1A2NCF1ADORA2ALMNAPDE10A | |
| SCHEMBL29118727 | 0.83 | NPC1 (0.43) | LMNAKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL17932793 | 0.83 | KMT2A (0.50) | CYP1A2ADORA2ALMNAPDE10AHPGDS | |
| SCHEMBL16189336 | 0.83 | KMT2A (0.50) | CYP1A2ADORA2ALMNAPDE10AHPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691983-B2 | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes | IDEMITSU KOSAN CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691983-B2 | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes | KCNQ2, KCNQ1, KCNQ4 | CYP1A2 1154/4885NCF1 2838/4885ADORA2A 2324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.